Clinical Trials Directory

Trials / Completed

CompletedNCT02375100

Transversus Abdominis Plane Block Versus Ilioinguinal Nerve Block for Pain Management in Inguinal Herniorraphy

Comparison of Efficacy of Transversus Abdominis Plane Block and Ilioinguinal Nerve Block for Postoperative Pain Management in Patients Undergoing Inguinal Herniorraphy With Spinal Anesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Bozyaka Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study compares efficacy of transversus abdominis plane block and ilioinguinal nerve block for postoperative pain in patients undergoing inguinal herniorraphy with spinal anesthesia. One-third of the patients will receive standard postoperative pain regimen(control group), one-third will receive a transversus abdominis plane block (with ultrasound guidance) and the last group will receive an ilioinguinal nerve block(with ultrasound guidance) in addition to standard postoperative pain regimen. This study is a Randomized prospective open-label controlled study.

Conditions

Interventions

TypeNameDescription
PROCEDURESpinal AnesthesiaAll patients will be administered 3ml of %0.5 bupivacaine through L3-L4 interspace to acquire motor and sensory blockade
PROCEDURETransversus Abdominis Plane BlockAnalgesic intervention which will be performed only to Transversus Abdominis Plane Block arm. It requires 20ml of %0.25 bupivacaine administration through a 22 G. x 4 in. (100 mm) Insulated Echogenic Needle with 30° Bevel from midaxillary line between costal margin and anterior superior iliac spine with ultrasound guidance
PROCEDUREIlioinguinal Nerve BlockAnalgesic intervention which will be performed only to Ilioinguinal Nerve Block arm. It requires 10ml of %0.25 bupivacaine administration through a 22 G. x 3-1/8 in. (80 mm) Insulated Echogenic Needle with 30° Bevel between umbilicus and iliac crest where the nerve is detected with ultrasound guidance
DRUGBupivacaine %0.5 (hyperbaric)
DRUGBupivacaine %0.25 (isobaric)
DEVICE25G Quincke needle
DEVICEEchogenic Needle with 30° bevel
DRUGAcetaminophenAnalgesic drug administration through iv and im route postoperatively. Patients are administered iv acetaminophen 1g twice a day routinely
DRUGTramadolPatients will be administered tramadol in postoperative period when their pain score exceeds 4 points (moderate pain)

Timeline

Start date
2015-02-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2015-03-02
Last updated
2015-10-28

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02375100. Inclusion in this directory is not an endorsement.